In News
New guidance on safety monitoring of medicines in children
EMA has published the new good pharmacovigilance practice (GVP) chapter IV on specific considerations for the paediatric population. The new GVP chapter covers approved medicines with a paediatric indication or with an ongoing paediatric development, but also medicines only approved for adults when they are used off-label to treat children, i.e....
Continue Reading 15 November, 2018